Abstract: The invention concerns a device for the fixation and manipulation of those tissues which are at least temporarily suitable for being fixed by suction. Hereby, tissues are understood to be, in addition to organic tissues, such as e.g. tissues of animals and humans, also inorganic tissues, such as films or textiles. In particular, the invention concerns a device for the fixation and manipulation of tissues which surround sensitive organs, such as e.g. the pericardium in humans. Furthermore, the invention concerns a method for the fixation and manipulation and, in particular, for puncturing of such tissues or the underlying areas.

Abstract: The invention relates to an arrangement which can be fixed to the inside of a cavity by means of fixing means which are associated with said arrangement. Said fixing means fix the arrangement in relation to at least one part of the wall of the cavity which is to be examined, wherein the arrangement must at least partially be inserted. Said arrangement enables the instruments, which are used to examine/manipulate cavities, even when the arrangement and/or the instrument is displaced in a translatory and/or rotational manner, in particular, in angled cavities, to be guided in a reliable manner.

Abstract: The use of selective imidazoline receptor agonists, such as moxonidine, rilmenidine, LNP-509, S-23515, PMS-812, PMS-847 and BU-98008, and their physiologically compatible acid addition salts in pharmaceutical preparations for the treatment and/or inhibition of functional disorders and/or diseases in larger mammals or humans which require inhibition or reduction of the activity of proteins which regulate the intracellular pH value and which belong to the superfamily of bicarbonate transporters, in particular the treatment or inhibition of clinical conditions of bones which are caused by an undesirable amount of bone resorption, such as osteoporosis; of diseases of the gastrointestinal tract, such as gastric ulcers; and of neuronal and/or neuropsychiatric diseases associated with a pathologically altered (especially increased) neuronal activity, such as depression, Alzheimer's disease, eating disorders and schizophrenia.

Abstract: The invention relates to apparatus puncturing, or manipulating in some other way, human or animal tissues, tissue attachment being reliably detected and communicated. In particular the apparatus of the invention allows accessing the cardiac sac after the pericardium has been pierced. The apparatus of the invention is applicable to any human or animal or organ tissue, foremost within the scope of minimally invasive surgery lacking direct visual monitoring and where it is necessary to make sure that tissue/organs be attached for purposes of manipulation, in particular puncturing, to a special, for instance puncturing apparatus. The invention is not restricted to living tissue/organs.

Abstract: The use of selective imidazoline receptor agonists, such as moxonidine, rilmenidine, LNP-509, S-23515, PMS-812, PMS-847 and BU-98008, and their physiologically compatible acid addition salts in pharmaceutical preparations for the treatment and/or inhibition of functional disorders and/or diseases in larger mammals or humans which require inhibition or reduction of the activity of proteins which regulate the intracellular pH value and which belong to the superfamily of bicarbonate transporters, in particular the treatment or inhibition of clinical conditions of bones which are caused by an undesirable amount of bone resorption, such as osteoporosis; of diseases of the gastrointestinal tract, such as gastric ulcers; and of neuronal and/or neuropsychiatric diseases associated with a pathologically altered (especially increased) neuronal activity, such as depression, Alzheimer's disease, eating disorders and schizophrenia.